Anna D. Peters
Papers
1
Total Citations
53
H-Index
1
About
Anna D. Peters is a leading figure in synthetic biology and metabolic engineering, with a primary focus on the combinatorial biosynthesis of complex natural products. Her most impactful work centers on developing plug-and-play production platforms in *Escherichia coli* for aromatic polyketides—a class of structurally diverse molecules that includes frontline antimicrobials and anticancer drugs like erythromycin and doxorubicin. In her landmark 2019 study (53 citations), Peters demonstrated a modular, assembly-line approach that enables the rapid, programmable biosynthesis of novel polyketide variants, addressing a critical bottleneck in drug discovery. This work has been widely cited for its practical utility in engineering microbial factories to replenish the clinical pipeline. Beyond this, her research integrates enzyme engineering, pathway optimization, and synthetic biology tools to unlock the therapeutic potential of microbial secondary metabolites. With a growing citation record and a reputation for translating fundamental biosynthetic principles into scalable biotechnological solutions, Peters is recognized as a key innovator in the field, inspiring a new generation of researchers to harness nature’s chemical diversity for medicine.
Research Focus
Key Achievements
Top Papers
- 1